Active Crohn’s patients with possible pancreas enzyme problems
Part of Digestive system clinical trials.
This study looks at how often people with active Crohn’s disease also have trouble digesting food because the pancreas may not release enough enzymes (exocrine pancreatic insufficiency). It may help doctors better recognize this hidden problem in people whose Crohn’s is currently active.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You have Crohn’s disease that has been diagnosed for more than 3 months.
- Your Crohn’s is considered “active” based on symptoms plus at least one test result (like blood inflammation markers, stool inflammation, or scans/endoscopy findings).
- Your doctor is planning or indicates a biologic treatment (anti-TNF, vedolizumab, or ustekinumab).
- You have not had chronic pancreatitis diagnosed before joining.
- You are not currently taking pancreatic enzyme replacement and you can safely take the planned biologic treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.
This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.
This study tests whether a special diet using a nutritional supplement can reduce inflammation and improve symptoms in people with active Crohn's disease affecting the small intestine. It aims to see how the diet changes gut bacteria and body composition.
This study tests whether a specific “exclusion diet” (removing certain foods) added to standard treatment can better control unstable Crohn’s disease in children. It may help reduce inflammation and flare-ups when symptoms are not controlled by usual medicines.
This trial tests a new, gentler way to diagnose Crohn's disease. If you have symptoms like long-lasting diarrhea or belly pain, this study may help find out if you have Crohn's without invasive procedures.
This trial tests whether enzymes from microbes work as well as enzymes from pigs to help people with chronic pancreatitis digest food better. It aims to find a treatment that reduces symptoms like pain and poor digestion.
Hear when a new Crohn Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.